TearScience Secures Up to $70M
TearScience Inc., a private medical device company, has sealed up to $70 million in funding from HealthCare Royalty Partners. The company is developing a system of treatment for evaporative dry eye. The infusion will be used for commercialization of its treatment.
26 February 2013•3 mins read
